Published: 2018-12-17

Acne & Rosacea

Atopic Dermatitis

GBR 830 Induced Progressive and Sustained Improvements in Atopic Dermatitis Skin Biomarkers and Clinical Parameters

Emma Guttman-yassky, Ana B Pavel, Yeriel Estrada, Lisa Zhou, Yacine Salhi, Girish Gudi, Vinu Ca, Julie Macoin, Jonathan Back, Gerhard Wolff
| DOI https://doi.org/10.25251/skin.2.supp.61

Page S61

Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses

Julie Macoin, Rami Lissilaa, Pavankumar Sancheti, Venkateshwar Reddy, Jonathan Back, Gerhard Wolff
| DOI https://doi.org/10.25251/skin.2.62

Page S62

Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis

Andreas Wollenberg, Emma Guttman-Yassky, Mathias Torpet, Jonathan I Silverberg
| DOI https://doi.org/10.25251/skin.2.supp.63

Page S63

Hyperhidrosis

Melanoma

Non-Melanoma Skin Cancers and Benign Cutaneous Tumors

Open-Label Study of A-101, a 40% Hydrogen Peroxide Topical Solution, in Patients With Seborrheic Keratosis

Valerie Callender, Ellen Frankel, Jonathan Weiss, William Werschler, Christopher Powala, Brian Beger, Esther Estes, Stuart Shanler
| DOI https://doi.org/10.25251/skin.2.supp.75

Page S75

Poster Presentations from FC23 Dermatology Conference®: Psoriasis

Miscellaneous

Rising Derm Stars® Abstracts